| |
Rant |
|
| |
Royally
pissed at GSK for their inaction regarding acknowledging
problems surrounding Paxil? Well, let it rip. This page
has been set up purely as a frustration release mechanism
.
Note,
please, that this is not a forum. Please do not leave
messages for each other (for this, you can use the chat
boards). It
is a virtual certainty that the company or its lawyers are
monitoring sites like these; feel free to address them directly.
|
|
|
| |
|
| |
|
Until the form below is activated,
please use the TEMPORARY
RANT guest book.
Please do not use it as a chat board:
there are already two
at your disposal.
In the meantime, why not contact the CEOs of GSK and
let them know what you are thinking. Please be civil
and avoid threats. Humour is an effective weapon.
Shame is even better.
Mr. David Stout
President
GlaxoSmithKline US Pharmaceuticals
5 Moore Drive,
Research Triangle Park, NC 27709
Mr. Jean-Pierre Garnier,
CEO
GlaxoSmithKline
1 Franklin Plaza
P.O. Box 7929
Philadelphia, PA 19101-7929
Fax: 215-751-7043
Mr. Jean-Pierre Garnier,
CEO
GlaxoSmithKline
Berkeley Avenue, Greenford
Middlesex, U.K. UB60NN
James B. D. Palmer, M.D.
Senior Vice President
New Product Development,
GlaxoSmithKline
5 Moore Drive, Research Triangle Park,
NC 27709
E-mail: jbdp0056@gsk.com
Dr. Tachi Yamada
GlaxoSmithKline
E-mail: tachi_yamada@gsk.com
|
|
|
|
| |
|
|
statistics/
Oct. 2002:
visitors:
14 396
visits: 20 958
page views: 82 891
|
|
|
|
|
| |
|
|
|
|
|
Donations will be used to
expand and enhance this site. Please be aware that Quitpaxil.org
does not have official charity status. Hence, no tax receipt
can be issued.
|
 
Site made in Canada
|
